trial · primary record
BG-92505
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 137 |
| Primary completion | 2028-08-29 |
| Primary endpoint | Number of Participants with Dose-Limiting Toxicities (DLTs) |
| Registry ID | NCT07896460 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:13.620Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07896460
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.